SpyGlass Pharma (SGP) Current Leases (2024)
SpyGlass Pharma (SGP) posted quarterly Current Leases of $442000.0 for Q4 2024.
Powered by 
Analysis
SpyGlass Pharma (SGP) Current Leases (2024) Analysis & Trends
SpyGlass Pharma (SGP) has reported Current Leases for 1 consecutive years, with $442000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Current Leases changed N/A year-over-year to $442000.0; the TTM figure through Dec 2024 stood at $442000.0 (changed N/A YoY), while the FY2024 annual figure was $442000.0, changed N/A from the prior year.
- Current Leases steadied at $442000.0 in Q4 2024 per SGP's latest filing.
- Across five years, Current Leases topped out at $442000.0 in Q4 2024 and bottomed at $442000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | SpyGlass Pharma | 973.76 Mn | 973.76 Mn | - | - |